BioCentury
ARTICLE | Clinical News

RGN-137: Phase II data

July 22, 2013 7:00 AM UTC

Molecular target: Not applicable

Description: Topical formulation of synthetic thymosin beta 4 (TB4), a naturally occurring 43-amino acid peptide...